Intellectual Property

Research Paper 53, September 2014

Regional Pooled Procurement of Medicines in the East African Community

This paper explores the current discussions in the East African Community (EAC) with regard to the establishment of a regional pooled procurement mechanism for essential medicines. (more…)

IP Negotiations Monitor 10, July 2014

The IP Negotiations Monitor summarizes the latest developments in multilateral and regional fora where intellectual property negotiations are taking place, and informs on upcoming meetings and events.

(Covering period: February 2014 – June 2014) (more…)

IP Negotiations Monitor 9, March 2014

The IP Negotiations Monitor summarizes the latest developments in multilateral and regional fora where intellectual property negotiations are taking place, and informs on upcoming meetings and events.

(Covering period: September 2013 – January 2014) (more…)

IP Negotiations Monitor 8, August 2013

The IP Negotiations Monitor summarizes the latest developments in multilateral and regional fora where intellectual property negotiations are taking place, and informs on upcoming meetings and events.

(Covering period: April – August 2013) (more…)

SouthViews No. 73, 26 June 2013

The man who saved millions with cheap medicines

By Martin Khor

His rivals called him a “pirate” but grateful millions whose lives were saved by his cheap generic medicines consider him a Robin Hood—Yusuf Hamied, leader of India’s giant company, Cipla.

(more…)

IP Negotiations Monitor 7, June 2013

The IP Negotiations Monitor summarizes the latest developments in multilateral and regional fora where intellectual property negotiations are taking place, and informs on upcoming meetings and events.

(Covering period January – March 2013) (more…)

SouthViews No. 61, 6 June 2013

Reflections on the IP System: A Development Perspective

By Carlos M. Correa

The South Centre held a side event during the 50th WIPO General Assemblies on the theme of “Reflections on the IP System: A Development Perspective” on 5 October 2012 at the WIPO headquarters in Geneva. Professor Carlos Correa, Special Advisor on Trade and Intellectual Property of the Centre, was the speaker of the event. Below is a summary of his presentation.

(more…)

Research Paper 47, May 2013

Access to Medicines and Intellectual Property: The contribution of the World Health Organization

The topic of intellectual property first appeared in the WHO in 1996 and coincided with the end of the Uruguay Round and the creation of the World Trade Organization. In 1995 the Charles III University of Madrid with the WHO Drugs Action Programme (DAP) organized a conference where Professor Carlos Correa presented a paper entitled “The Uruguay Round and Drugs”. (more…)

SouthViews No. 60, 15 April 2013

The Use of Compulsory Licenses in Latin America

By Carlos M. Correa

This article examines the situation in Latin American countries with respect to their laws and policies relating to compulsory licenses—and how Brazil and Ecuador have made use of such compulsory licenses for drugs.

(more…)

SouthViews No. 51, 13 December 2012

India prepares to supply free generic medicines

By Zofeen Ebrahim

As the northern Indian state of Rajasthan rolls out an ambitious universal healthcare plan, the discontent of the state’s doctors stands in stark contrast to the joys of the 68 million people who will benefit from the scheme.

(more…)

SouthViews No. 37, 22 October 2012

Asian countries act to get cheap drugs

By Martin Khor

Staring with Malaysia in 2003, many Asian countries are now taking actions to promote cheaper medicines through compulsory licensing, with Indonesia being the latest case.
(more…)

SouthViews No. 32, 18 September 2012

India to increase supply of free generic medicines: some key issues

By Nirmalya Syam

Recent reports indicate that the Indian government plans to increase manifold its spending on procurement of generic medicines for supply free to patients. This is welcome news. However, it is important to ensure future supply of generic medicines by addressing the present problems facing the Indian drug industry.

(more…)